The AGA Institute Process for Developing Clinical Practice Guidelines Part One: Grading the Evidence

被引:70
作者
Sultan, Shahnaz [1 ,2 ]
Falck-Ytter, Yngve [3 ,4 ]
Inadomi, John M. [5 ]
机构
[1] Univ Florida, Coll Med, Malcom Randall VA Med Ctr, Gainesville, FL USA
[2] Univ Florida, Coll Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA
[3] Case Western Reserve Univ, Sch Med, Louis Stokes VA Med Ctr, Cleveland, OH USA
[4] Case Western Reserve Univ, Sch Med, Dept Med, Div Gastroenterol,Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA
[5] Univ Washington, Sch Med, Dept Med, Div Gastroenterol, Seattle, WA 98195 USA
关键词
INFLAMMATORY-BOWEL-DISEASE; METAANALYSIS; QUALITY; EFFICACY;
D O I
10.1016/j.cgh.2013.02.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This article, by Dr John Inadomi and colleagues, is the first of a 2-part series (the second part to be published later this year) on the AGA's process for developing guidelines. The importance of guidelines has increased considerably over the last 25 years. In the first wave of managed care, we were practicing with few if any clinical guidelines. Now, as we move forward toward a value-based reimbursement system, the need for evidence-based practice is paramount. Dr Inadomi and the AGA Clinical Practice and Quality Management Committee have fine-tuned this process over the last 3 years and now describe their results. While many guidelines are labeled as "GRADE," some are simply opinion documents designed with GRADE wording. A fully implemented GRADE process involves rigorous analysis of published data, input from trained GRADE methodologists, and opportunities for both public and expert comment from all involved stakeholders. John I. Allen, MD, MBA, AGAF Special Section Editor
引用
收藏
页码:329 / 332
页数:4
相关论文
共 9 条
[1]   Proton Pump Inhibitors vs. Histamine 2 Receptor Antagonists for Stress-Related Mucosal Bleeding Prophylaxis in Critically III Patients: A Meta-Analysis [J].
Barkun, Alan N. ;
Bardou, Marc ;
Pham, C. Q. D. ;
Martel, Myriam .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (04) :507-520
[2]   The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis [J].
Desai, Tusar K. ;
Krishnan, Kumar ;
Samala, Niharika ;
Singh, Jashanpreet ;
Cluley, John ;
Perla, Subaiah ;
Howden, Colin W. .
GUT, 2012, 61 (07) :970-976
[3]   Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis [J].
Ford, Alexander C. ;
Sandborn, William J. ;
Khan, Khurram J. ;
Hanauer, Stephen B. ;
Talley, Nicholas J. ;
Moayyedi, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04) :644-659
[4]  
Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1
[5]   GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations [J].
Guyatt, Gordon H. ;
Oxman, Andrew D. ;
Vist, Gunn E. ;
Kunz, Regina ;
Falck-Ytter, Yngve ;
Alonso-Coello, Pablo ;
Schuenemann, Holger J. .
BRITISH MEDICAL JOURNAL, 2008, 336 (7650) :924-926
[6]   Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis [J].
Khan, Khurram J. ;
Dubinsky, Marla C. ;
Ford, Alexander C. ;
Ullman, Thomas A. ;
Talley, Nicholas J. ;
Moayyedi, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04) :630-642
[7]   INNOVATION PROFILE How Geisinger Structures Its Physicians' Compensation To Support Improvements In Quality, Efficiency, And Volume [J].
Lee, Thomas H. ;
Bothe, Albert ;
Steele, Glenn D. .
HEALTH AFFAIRS, 2012, 31 (09) :2068-2073
[8]   Is there publication bias in the reporting of cancer risk in Barrett's esophagus? [J].
Shaheen, NJ ;
Crosby, MA ;
Bozymski, EM ;
Sandler, RS .
GASTROENTEROLOGY, 2000, 119 (02) :333-338
[9]   Health Care Spending and Quality in Year 1 of the Alternative Quality Contract [J].
Song, Zirui ;
Safran, Dana Gelb ;
Landon, Bruce E. ;
He, Yulei ;
Ellis, Randall P. ;
Mechanic, Robert E. ;
Day, Matthew P. ;
Chernew, Michael E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (10) :909-918